An Analysis of Studies Comparing Myocarditis and Pericarditis in COVID-19 Vaccinated and SARS-CoV-2 Infected Individuals.

Publication date: Jul 05, 2025

We sought to identify studies that examined myocarditis and pericarditis after both COVID-19 vaccination and SARS-CoV-2 infection. A literature search was conducted and retrospective cohort studies examining incidence rates for myocarditis and pericarditis after both COVID-19 vaccination and SARS-CoV-2 infection were included. The methodologies and conclusions of each study was assessed, and a risk of bias was determined. We found 6 articles that utilized cohorts from the same population. Of the included articles, all of them had risk of bias concerns with 50% having a poor-quality rating and 50% having a fair quality rating. Methodological biases, including reliance on EHR data, inadequate observational periods, and failure to account for baseline characteristics between the two cohorts, were observed across studies. Ultimately, these methodological limitations lead to hyperinflated myocarditis rates in the infection cohorts and a lack of meaningful comparisons between the infection and vaccination cohorts.

Concepts Keywords
Covid COVID-19 infection
Methodological COVID-19 vaccination
Myocarditis Myocarditis
Vaccinated Pericarditis
SARS-CoV-2

Semantics

Type Source Name
disease MESH Myocarditis
disease MESH Pericarditis
disease MESH COVID-19
pathway REACTOME SARS-CoV-2 Infection
disease IDO quality
disease MESH infection
disease MESH Long Covid

Original Article

(Visited 2 times, 1 visits today)